Data on Phase 2 Dep Docetaxel and Dep Cabazitaxel human trials
Completion of recruitment and treatment of Viraleze™ human trial
Share price appreciation to reflect the above
Announcement of replacement for CEO
Announcement of retirement of Chairman
Hopefully new submission to FDA for NDA of Vivagel
Announcement of new partners for distribution of Vivagel_b with substantial up front licensing fees
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
10.0¢ |
Change
0.003(3.09%) |
Mkt cap ! $41.82M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 10.0¢ | 9.8¢ | $1.054K | 10.54K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 89458 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 232823 | 5 |
View Market Depth
| Last trade - 15.49pm 16/07/2025 (20 minute delay) ? |
| SPL (ASX) Chart |